Based on the study findings, serum FGF23 levels were elevated in patients with Cerebral Infarction (CI) and Vertebral-Basilar Insufficiency (VBI), suggesting the potential use of serum FGF23 levels for diagnosing CI. Here, FGF23 is linked to cerebral infarction.